Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer
Clinical trial NCT02726503 · COMPLETED
Trial details
- NCT number
- NCT02726503
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-04
- Primary completion
- 2020-02-25
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.